Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

331 ARTÍCULOS , VIENDO DEL 76 AL 90

Immunotherapy Applied to Neuropsychiatric Disorders: a New Perspective of Treatment

Prior PL.

J Mol Neurosci. 2015 Sep;57(1):139-41. doi: 10.1007/s12031-015-0587-5. Epub 2015 May 31.

Multiple Ligands Targeting Cholinesterases and β-Amyloid: Synthesis, Biological Evaluation of Heterodimeric Compounds with Benzylamine Pharmacophore

Szałaj N, Bajda M, Dudek K, Brus B, Gobec S, Malawska B.

Arch Pharm (Weinheim). 2015 Aug;348(8):556-63. doi: 10.1002/ardp.201500117. Epub 2015 May 29.

The effectiveness and safety of acupuncture for patients with Alzheimer disease: a systematic review and meta-analysis of randomized controlled trials

Zhou J, Peng W, Xu M, Li W, Liu Z.

Medicine (Baltimore). 2015 Jun;94(22):e933. doi: 10.1097/MD.0000000000000933.

Herbs to curb cyclic nucleotide phosphodiesterase and their potential role in Alzheimer's disease

Kumar A, Sharma V, Singh VP, Kaundal M, Gupta MK, Bariwal J, Deshmukh R.

Mech Ageing Dev. 2015 Jul;149:75-87. doi: 10.1016/j.mad.2015.05.009. Epub 2015 Jun 4.

Phytochemicals that regulate neurodegenerative disease by targeting neurotrophins: a comprehensive review

Venkatesan R, Ji E, Kim SY.

Biomed Res Int. 2015;2015:814068. doi: 10.1155/2015/814068. Epub 2015 May 14.

Abnormal Glucose Metabolism in Alzheimer's Disease: Relation to Autophagy/Mitophagy and Therapeutic Approaches

Banerjee K, Munshi S, Frank DE, Gibson GE.

Neurochem Res. 2015 Dec;40(12):2557-69. doi: 10.1007/s11064-015-1631-0. Epub 2015 Jun 16.

Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US

Saint-Laurent Thibault C, Özer Stillman I, Chen S, Getsios D, Proskorovsky I, Hernandez L, Dixit S.

J Med Econ. 2015;18(11):930-43. doi: 10.3111/13696998.2015.1063501. Epub 2015 Aug 26.

Alzheimer's Disease, Drosophila melanogaster and Polyphenols

Jimenez-Del-Rio M, Velez-Pardo C.

Adv Exp Med Biol. 2015;863:21-53. doi: 10.1007/978-3-319-18365-7_2.

Biflavonoids as Potential Small Molecule Therapeutics for Alzheimer's Disease

Thapa A, Chi EY.

Adv Exp Med Biol. 2015;863:55-77. doi: 10.1007/978-3-319-18365-7_3.

Being human: The role of pluripotent stem cells in regenerative medicine and humanizing Alzheimer's disease models

Sproul AA.

Mol Aspects Med. 2015 Jun-Oct;43-44:54-65. doi: 10.1016/j.mam.2015.06.007. Epub 2015 Jun 19.

Current Practices in the Treatment of Alzheimer Disease: Where is the Evidence After the Phase III Trials?

Ehret MJ, Chamberlin KW.

Clin Ther. 2015 Aug;37(8):1604-16. doi: 10.1016/j.clinthera.2015.05.510. Epub 2015 Jun 27.

Serum Anticholinergic Activity as an Index of Anticholinergic Activity Load in Alzheimer's Disease

Hachisu M, Konishi K, Hosoi M, Tani M, Tomioka H, Kitajima Y, Inamoto A, Hirata A, Koganemaru T, Tomita A, Akashi N, Hori K.

Neurodegener Dis. 2015;15(3):134-9. doi: 10.1159/000381483. Epub 2015 Jun 30.

Beyond the Hypothesis of Serum Anticholinergic Activity in Alzheimer's Disease: Acetylcholine Neuronal Activity Modulates Brain-Derived Neurotrophic Factor Production and Inflammation in the Brain

Hachisu M, Konishi K, Hosoi M, Tani M, Tomioka H, Inamoto A, Minami S, Izuno T, Umezawa K, Horiuchi K, Hori K.

Neurodegener Dis. 2015;15(3):182-7. doi: 10.1159/000381531. Epub 2015 Jun 30.

Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease

Barage SH, Sonawane KD.

Neuropeptides. 2015 Aug;52:1-18. doi: 10.1016/j.npep.2015.06.008. Epub 2015 Jul 2.

The Innate Immunity in Alzheimer Disease- Relevance to Pathogenesis and Therapy

Blach-Olszewska Z, Zaczynska E, Gustaw-Rothenberg K, Avila-Rodrigues M, Barreto GE, Leszek J, Aliev G.

Curr Pharm Des. 2015;21(25):3582-8. doi: 10.2174/1381612821666150710144829.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias